To investigate the possible role of the vasculature in the local regulation of corpus luteum (CL) function, we determined the densities of capillaries and large blood vessels in the center of the bovine CL during the estrous cycle and following prostaglandin (PG) F2α-induced luteolysis. The CLs at the early (Days 2-3 post-ovulation), developing (Days 5-7), mid , late and regressed (Days 19-21) stages were collected. In addition, the CLs were collected by transvaginal ovariectomy from 12 cows (Day 10 after ovulation), i.e., non-treated (n=3, 0 h, control), at 0.5 (n=3), 2 (n=3) and 12 h (n=3) after injection of a luteolytic dose of PGF2α. Immunohistochemical staining with von Willebrand Factor (specific for endothelial cells that are found in both types of blood vessels) revealed that the density of the luteal blood vessels was significantly higher at the developing and late luteal stages (P<0.05) than at the other stages, whereas the number of larger blood vessels (those stained with α-smooth muscle actin) was higher at the late and regressed luteal stages (P<0.05) than at the other stages. Furthermore, both the density of blood vessels and the number of blood vessels with smooth muscle were significantly higher in the CLs obtained at 2 h and 12 h after PGF2α administration (P<0.05) than in those without PGF2α treatment. These results suggest that the number of blood vessels with smooth muscle per unit area in the regressing CL increased as a result of losing steroidogenic cells and capillaries. The overall results demonstrate that the capillaries disappeared earlier than the large blood vessels during structural luteolysis and suggest that the loss of capillaries in the CL results in a reduced supply of nutrients and oxygen to luteal cells followed by cell death. . It reaches structural and functional maturity by the mid-luteal phase and then begins to regress after Day 17 post-ovulation of the nonfertile cycle. Luteal regression in cows is known to be induced by uterine prostaglandin (PG) F2α until the CL is completely degraded. In cows, luteal regression is characterized by a reduction in P4 production (functional luteolysis) and tissue degeneration by apoptosis (structural luteolysis) [2, 3] .
(J. Reprod. Dev. 55: 512-517, 2009) he corpus luteum (CL) is a transient organ that forms from the wall of a Graafian follicle following ovulation and secretes progesterone (P4) [1] . It reaches structural and functional maturity by the mid-luteal phase and then begins to regress after Day 17 post-ovulation of the nonfertile cycle. Luteal regression in cows is known to be induced by uterine prostaglandin (PG) F2α until the CL is completely degraded. In cows, luteal regression is characterized by a reduction in P4 production (functional luteolysis) and tissue degeneration by apoptosis (structural luteolysis) [2, 3] .
The development of the bovine CL is known to be associated with an intensive angiogenic process. The intensity of this angiogenic process in the developing CL is similar to the intensities of angiogenesis in the fastest growing tumors [4] , and this results in the mature CL becoming one of the most highly vascularized organs in the body [5] [6] [7] and vascular endothelial cells accounting for up to 50% of the total cells of the mid CL [8, 9] . Furthermore, luteal endothelial cells have been known to secrete some vasoactive substances that directly regulate P4 secretion within the CL [10] [11] [12] . Therefore, in order to know the mechanisms regulating the function of the bovine CL, it is important to investigate the changes in the luteal vasculature.
Recently, capillaries and a few blood vessels with smooth muscle were found in the center of the mid bovine CL [13] . These two types of blood vessels differ not only structurally but also functionally. Whereas micro-capillary blood vessels, which consist of a single layer of endothelial cells attached to a basement membrane, permit exchanges of materials between the blood and the surrounding luteal cells, large blood vessels with a smooth muscle layer are specialized in the transport of hormones, nutrients and metabolites. The changes of both types of blood vessels in the CL throughout the estrous cycle remain unclear.
Administration of a luteolytic dose of PGF2α induces an acute increase in blood flow followed by luteal regression in the CL of Days 6-17 after ovulation but not in the early CL (Days 1-5 after ovulation) [14] . This vascular change after PGF2α injection is more evident in the surface than in the center of the mid CL [15] . In addition, endothelial cells are the first type of cells to undergo apoptosis during luteolysis [16, 17] . However, our recent in vitro studies demonstrated that steroidogenic cells from the bovine mature CL do not undergo apoptosis after treatment with PGF2α in the absence of endothelial cells [18] , suggesting that the luteal vasculature plays some important roles during luteolysis and that the luteolytic action of PGF2α is mediated by endothelial cells. How-ever, there is little information about the changes in luteal vasculature after administration of PGF2α in cattle.
The aim of the present study was to investigate the changes in the density and number of blood vessels, with and without smooth muscle, throughout the estrous cycle and after administration of PGF2α in the bovine CL.
Materials and Methods

Animal tissue collection
For determination of the vascular changes throughout the estrous cycle, ovaries with CLs of Holstein cows were obtained from a local abattoir in accordance with protocols approved by the local institutional animal care and use committee. Ovaries were obtained within 30 min after exsanguination and were transported to the laboratory within 1-1.5 h on ice. Luteal stages were classified as being early (Days 2-3 after ovulation), developing (Days 5-7), mid (Days 8-12), late (Days 15-17) and regressed (Days 19-21) by macroscopic observation of the ovary and uterus as described previously [19, 20] .
The animal procedures were approved by the local institutional animal care and use committee in Olsztyn, Poland (Agreement No. 5/2007, 6/2007 and 88/2007). Healthy, normally cycling Polish Holstein Black and White cows were used for collection of CLs. Estrus was synchronized in the cows by two injections of an analogue PGF2α (dinoprost, Dinolytic; Upjohn -Pharmacia N.V.S.A., Belgium) with an 11-day interval. Ovulation was determined by a veterinarian via per rectum USG examination using a DRAMIN-SKI Animal Profit Scanner (Draminski Electronics in Agriculture, Olsztyn, Poland). To determine the effect of PGF2α on luteal vasculature, the ovaries were collected from 12 cows through colpotomy using a Hauptner's effeninator (Hauptner & Herberholz, Solingen, Germany) on Day 10 post-ovulation, i.e., non-treated (0 h, control, n=3), and at 0.5 (n=3), 2 (n=3) and 12 h (n=3) after injection of a luteolytic dose of PGF2α analogue (cloprostenol; Bioestrophan, Biowet, Gorzow Wielkopowski, Poland).
CLs were enucleated from the ovary and dissected free of connective tissue. Tissue samples were fixed in 10% (v/v) neutral phosphate buffer formalin (pH 7.0) for 24 h at room temperature and then embedded in paraffin wax. The samples were cut into 4-μm sections and mounted onto glass microscope silanized slides (Dako).
Immunohistochemistry
Immunohistochemical staining was performed by the avidinbiotin peroxidase complex (ABC) method [21] . The sections were dehydrated in a graded series of ethanol, cleared in xylene, embedded in paraffin and treated with 0.3% H2O2 in methanol for 10 min at room temperature to inactivate endogenous peroxidase. The slides were then washed in 0.01 M PBS (pH 7.4). After treatment with normal goat serum (2%) for 30 min at room temperature, the sections were incubated with a polyclonal von Willebrand factor antibody (vWF: diluted 1 : 1000; 228160; Lab Vision Corporation, Fremont, CA, USA), which is a marker of endothelial cells, and a monoclonal α-smooth muscle actin antibody (ASM-1: 65001; PROGEN Biotechnik GmbH, Heidelberg, Germany; directly used as provided by the supplier without further dilution), which is a marker of smooth muscle, overnight at 4 C. As a negative control, the sections were incubated with goat anti-rabbit IgG overnight at 4 C. After incubation, the sections were washed in PBS, incubated for 30 min at room temperature with biotinylated goat anti-rabbit IgG (diluted 1 : 200; Vector Laboratories, Burlingame, CA, USA) for vWF and the negative control and with biotinylated goat antimouse IgG (diluted 1 : 200; Vector Laboratories) for ASM-1 and then washed in PBS. Horseradish peroxidase (HRP)-conjugated ABC (Vector Laboratories) combined with secondary antibody was applied to tissue slides at room temperature for 30 min. The binding sites were visualized with 0.02% 3,3'-diaminobenzidine tetrahydrochloride (DAB) in 50 mM Tris-HCl (pH 7.4) containing 0.02% H2O2. After immunohistochemical staining, the sections were lightly counterstained with Mayer's hematoxylin. The sections were washed in DW, dehydrated in a graded series of ethanol, cleared in xylene and coverslipped.
Quantification methods
To calculate the density of blood vessels (%) and the number of blood vessels with smooth muscle, sections of the center of the CL without connective tissue were selected randomly and examined at × 400 magnification.
An eyepiece grid covered each area (approximately 0.13 mm 2 ) on the sections. The blood vessels were counted by the "pointcount method" as described previously [22] with some modifications. Briefly, each crosshair on the grid that coincided with positive immunostaining or a capillary lumen was counted. The percentage of blood vessels in the CL was calculated as X/Y × 100, where X was the total number of points that coincided with positive immunostaining or a capillary lumen and Y was the total number of points on a unit area [23, 24] . The density of the microvessels was expressed as a percentage mean ± SEM. The number of ASM-1-positive lumina was counted in an area of approximately 0.13 mm 2 and expressed as the number of blood vessels with a smooth muscle layer as shown in Figs. 4 and 5. Three sections from the center of the CL were randomly chosen from each animal, and counting was performed for three randomly chosen areas on each section (microscopic field).
Statistical analysis
All experimental data are shown as the mean ± SEM. The statistical significances for the density of vessels and the number of blood vessels with a smooth muscle layer were assessed by ANOVA followed by a Fisher protected least significant difference procedure (PLSD) as a multiple comparison test.
Results
Changes in the density of luteal blood vessels
Some large blood vessels were observed between immature luteal cells at the early luteal stage (Fig. 1A) . The developing luteal stage was characterized by a dense network system of blood vessels (Fig. 1B) . The density of the blood vessels decreased at the mid luteal stage and then increased at the late luteal stage (Figs. 1C and  D) . Several large blood vessels were observed in the regressed CL (Fig. 1E) .
The network of clear blood vessels was less developed in the CLs without PGF2α administration (control) than in the CLs collected at 0.5, 2 and 12 h after PGF2α administration (Figs. 2B, C  and D) .
The densities of blood vessels at the developing and late luteal stages were significantly higher than those at the other luteal stages. Interestingly, the densities of the luteal blood vessels at 0.5, 2 and 12 h after PGF2α administration were higher than in the CLs without PGF2α treatment (control; Fig. 3 ).
Changes in the number of luteal blood vessels with smooth muscle
There was no significant change in the number of blood vessels with smooth muscle in the center of the CL from the early to midluteal stages (Figs. 4A, B, C and 6A) . However, the number of blood vessels with smooth muscle significantly increased (P<0.05) at the late and regressed luteal stages (Figs. 4D, E and 6A ). The number of blood vessels with smooth muscle did not change significantly at 0.5 h after PGF2α administration (Fig. 5B) , but increased at 2 h (P<0.05) and further increased at 12 h (P<0.05) after PGF2α administration (Figs. 5C, D and 6B) . A clear increase in the number of large blood vessels with smooth muscle was observed at 12 h after PGF2α administration (Fig. 5D) . The number of blood vessels was determined by counting the number of ASM-1-positive vessels per unit area in the histological section at × 400 magnification. Counting was performed for three randomly chosen areas (microscopic fields). Different letters indicate significant differences (P<0.05) as assessed by ANOVA followed by a Fisher's protected least significant difference procedure (PLSD) as a multiple comparison test.
Discussion
Angiogenesis has been shown to be necessary for establishing the CL and maintaining its function [8] . The CL is one of the most highly vascularized organs in the body [9] . Although the changes in the density and localization of endothelial cells have been reported in the bovine CL throughout the estrous cycle [25] , the changes in luteal microvasculature and large blood vessels with smooth muscle have not been studied [14] . In the present study, the density of blood vessels at the developing and late luteal stages was higher than at the other stages. Interestingly, vascular density decreased from the developing to mid-luteal stages and then increased at the late luteal stage. The decrease in the density of blood vessels at the mid-luteal stage was associated with the maximum volume of the CL and full growth of luteal steroidogenic cells. Moreover, the number of blood vessels with a smooth muscle layer per unit area increased at the late and regressed luteal stages. In contrast, the density of blood vessels decreased at the regressed luteal stage. Previous studies have demonstrated that the number of luteal endothelial cells positively stained with angiopoietin-2 (ANPT-2) antibody increases in the bovine CL at the regressed stage [26] , and that infusion of ANPT-2 (100 ng/ml) acutely inhibits P4 release from the late CL [27] . The above findings suggest that a decrease in the density of blood vessels and P4 production in the regressing CL occurs due to a destabilization of capillary blood vessels induced by ANPT-2.
Injecting a cow with PGF2α at the mid-luteal phase decreases P4 production and subsequently induces luteal cell death (apoptosis) [28] [29] [30] . However, in vitro studies have demonstrated that PGF2α increases P4 production and cell viability in cultured bovine luteal steroidogenic cells [18, 31] . Interestingly, a decrease in P4 has been observed after co-culture of bovine luteal steroidogenic cells with aorta endothelial cells and exposure to PGF2α [32] . These findings suggest that vascular components (endothelial cells) and some of their secretory products are crucial for the luteolytic action of PGF2α. In the present study, the densities of the blood vessels at 0.5, 2 and 12 h after PGF2α administration were significantly higher than in the untreated CLs (control). Injecting cows with a luteolytic dose of PGF2α has been demonstrated to induce an acute increase in blood flow from 0.5 to 2 h after injection in the periphery of the mature CL, but not in the early CL [14, 15] . Recently, we demonstrated that PGF2α administration increased the levels of oxygen (pO2) and NO in the ovarian venous blood between 0.5 and 2 h post-treatment [33] . These findings suggest that the increase of blood vessel density at 0.5 h after PGF2α administration is caused by vasodilatation, which is associated with an increase in blood supply not only in the periphery but also in the center of the CL.
PGF2α receptors are present in bovine luteal endothelial cells [34] [35] [36] , and PGF2α has been demonstrated to increase nitric oxide (NO) production in endothelial cells [37] , which induces luteal cell apoptosis in the human [38] and cow [39] . These findings suggest that vascular components including endothelial cells play an important role in luteolysis. Therefore, it is important to determine the changes in the density and number of blood vessels. The present results, which show that the density of blood vessels increased after PGF2α administration, suggest that acute changes in the vasculature is associated with the initiation of functional and structural luteolysis. However, there was no significant change in the density of blood vessels, including both capillaries and blood vessels with smooth muscle, between 0.5 and 12 h after PGF2α administration, whereas, the number of blood vessels with smooth muscle was significantly increased at 12 h compared with 0.5 h. The findings suggest that blood vessels without smooth muscle, i.e., capillaries, disappear earlier than larger vessels with smooth muscle in the CL during luteolysis. The number of blood vessels with smooth muscle per unit area might increase as a result of loss of steroidogenic cells and capillaries in the regressing CL.
The overall results demonstrate that capillaries lacking smooth muscle disappear earlier than blood vessels with a smooth muscle layer during structural luteolysis and suggest that the loss of capillaries results in a reduced supply of nutrients to luteal cells followed by luteal cell death.
